Resolvin D1 binds human phagocytes with evidence for proresolving receptors
Sriram Krishnamoorthy, Antonio Recchiuti, Nan Chiang et al. · Proceedings of the National Academy of Sciences · 2010
Endogenous mechanisms that act in the resolution of acute inflammation are essential for host defense and the return to homeostasis. Resolvin D1 (RvD1), biosynthesized during resolution, displays potent and stereoselective anti-inflammatory actions, such as limiting neutrophil infiltration and proresolving actions. Here, we demonstrate that RvD1 actions on human polymorphonuclear leukocytes (PMNs) are pertussis toxin sensitive, decrease actin polymerization, and block LTB(4)-regulated adhesion molecules (beta2 integrins). Synthetic [(3)H]-RvD1 was prepared, which revealed specific RvD1 recognition sites on human leukocytes. Screening systems to identify receptors for RvD1 gave two candidates--ALX, a lipoxin A(4) receptor, and GPR32, an orphan--that were confirmed using a beta-arrestin-based ligand receptor system. Nuclear receptors including retinoid X receptor-alpha and peroxisome proliferator-activated receptor-alpha, -delta, -gamma were not activated by either resolvin E1 or RvD1 at bioactive nanomolar concentrations. RvD1 enhanced macrophage phagocytosis of zymosan and apoptotic PMNs, which increased with overexpression of human ALX and GPR32 and decreased with selective knockdown of these G-protein-coupled receptors. Also, ALX and GPR32 surface expression in human monocytes was up-regulated by zymosan and granulocyte-monocyte-colony-stimulating factor. These results indicate that RvD1 specifically interacts with both ALX and GPR32 on phagocytes and suggest that each plays a role in resolving acute inflammation.
Cited by 730 works. doi:10.1073/pnas.0907342107
Authors
- Antonio Recchiuti
- Nan Chiang
- Stephanie Yacoubian
- Chih‐Hao Lee
- Rong Yang
- Nicos A. Petasis
- Charles Nicholas Serhan
References
- Cancer-related inflammation
- Neutrophil Mac-1 and MEL-14 Adhesion Proteins Inversely Regulated by Chemotactic Factors
- Seven-transmembrane receptors
- Resolvins
- Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1
- Resolution Phase of Inflammation: Novel Endogenous Anti-Inflammatory and Proresolving Lipid Mediators and Pathways
- INFLAMMATION AND ATHEROSCLEROSIS
- Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor.
- Annexin A1 and glucocorticoids as effectors of the resolution of inflammation
- Resolvin E1 Selectively Interacts with Leukotriene B4 Receptor BLT1 and ChemR23 to Regulate Inflammation